About

The global diabetes epidemic has tripled since 2000, to some 430 million persons worldwide, and is expected to exceed 600 million by 2045. Two-thirds of persons with diabetes develop diabetic retinopathy and one-third develop sight-threatening diabetic retinopathy over twenty years. These patients are at high risk of vision impairment or even blindness if not diagnosed and treated in a timely manner.

Systematic eye screening and preventive treatment are known to dramatically reduce diabetic blindness. The RetinaRisk App is a clinically-validated risk calculator that allows persons with diabetes to assess in real-time their individualized risk for sight-threatening diabetic retinopathy, based on their risk profile, and to track the progression of the disease over time. It includes detailed guidelines and useful information on diabetes, diabetic retinopathy and improved self-care, which allows patients to better understand their condition and become an active participant in their own wellness journey.

The RetinaRisk App empowers persons with diabetes to become more involved in their health care decision-making. It supports patient self-management by demonstrating the importance of regular eye examinations and seeking timely medical assistance. It motivates persons with diabetes to become more responsible and better-informed patients. The App’s easy-to-visualize, effective and efficient patient education tools vividly demonstrate how improvement of modifiable risk factors (e.g., blood glucose, HbA1c, blood pressure) could significantly lower the risk of potentially blinding diabetic eye disease and expensive interventions.

The RetinaRisk team is qualified, energetic and passionate about transforming diabetes education and care, with over 30 years of academic and clinical experience in managing and treating diabetes and diabetic retinopathy. We have a vision to improve diabetes care and delivery by applying technology and epidemiological data to improve outcomes, focus on patients at highest risk, and save money. This is mobile, digital health at the user´s fingertips.

The Company

Risk Medical Solutions (RMS) was founded in 2009 by professors Einar Stefánsson, MD – Retinal Specialist and Chair of the Landspitali University Hospital Department of Ophthalmology, and Arna Guðmundsdóttir, MD – Diabetologist at Landspitali University Hospital, Department of Endocrinology.  RMS is comprised of 12 Icelanders specialized in medicine, mathematics, statistics, computer programming, health care economics and business.

The company has received significant support from the academic and healthcare community in Iceland and has received grants from the Icelandic Technology Development Fund, the Icelandic Innovation Center, and commercial banks amongst others. Its initial round of private investment was completed in 2011. Amongst shareholders are the University of Iceland and the Icelandic University Hospital, who both contribute significant resources towards our work.

Ground-Breaking Collaboration

The RetinaRisk™ system has been developed and refined thanks to innovative collaboration between an ophthalmologic retinal specialist, an endocrinologist specializing in diabetes, an optometrist specializing in diabetes care and education, a team of colleague physicians, as well as experts in mathematics, biostatistics, computer science, epidemiology, health care economics and business.

Each specialist brought their unique clinical training, experience and professional expertise to bear on the goal of creating an accurate, powerful, easy-to-use system for eye care providers, primary care physicians, endocrinologists, other health care personnel, and patients alike.

Our expert team solicited feedback from a variety of stakeholders, including many global health care professionals and people living with diabetes, to create and refine imaginative and user-friendly features, including customized communications, patient education materials, and top-flight diabetes resources for health care providers.